We are here. Researchers have finally developed an Ebola virus vaccine that is able to provide 100-percent protection against one particularly deadly strain of the disease based on final field tests on thousands of people in West Africa.
A recent study provides more insight about Ebola transmissions and launches new interactive tool to map threatened areas.
While some bat species have evolved with a resistance to Ebola, the virus in turn has evolved to overcome that resistance. Researchers have targeted the biological factors responsible for this resistance, which may aid Ebola prevention and outbreak management in the future.
Admittedly, Ebola is still a very real issue, with a grand total of 18 confirmed cases of the often fatal disease indentified in West Africa, as of this week. However, compared to the whopping 450 to 1,000 weekly cases reported in the peak of last year's epidemic, it's safe to say that the worst is over. But now, experts are looking back and wondering what could have been done better. The burial of victims, according to a new report, is one issue that should have been better addressed.
The Ebola outbreak, which made headlines just last year, is slowly-but-surely coming under control, according to the World Health Organization (WHO) and public health initiatives. It's no secret that to prevent future outbreaks, experts are scrambling to create an effective vaccine. However, that kind of work takes time, and immunization isn't always available. That's why it's equally good news to hear that, for the first time, a medicinal approach for treating Ebola has seen some success in early trials.
The Ebola outbreak, which made headlines just last year, is slowly but surely coming under control, according to the World Health Organization (WHO) and public health initiatives. However, it took a long time and countless deaths to get to this point - something that the WHO says is unacceptable. Now the organization is admitting to partial fault for this disaster, with its investigators and directors quick to say that they will make use of the lessons they have learned moving forward.
The Ebola outbreak, which made headlines just last year, is slowly but surely coming under control, according to the World Health Organization and public health initiatives. Now, researchers are saying that there is hope that it will soon never resurface in epidemic proportions again, as an experimental vaccine called VSV-ZEBOV was recently found to be both safe and effective in early human trials.
The idea that wild animals such as bats and gorillas could be the culprits of the Ebola epidemic sweeping across West Africa is nothing new. But now a new study suggests that insectivorous free-tailed bats, which weren't previously implicated in the outbreak, may be behind the deadly disease.
Good news from the scientific front in the fight against Ebola. Researchers have determine that an inhalable version of an experimental Ebola vaccine is not only possible, its proven to be very promising in animal testing, doing just as well as an injected version.
Experts have decoded the genetic factors that contribute to an Ebola patient's susceptibility to the virus, potentially helping to determine who faces the greatest risk of deadly symptoms.
The highly controversial and fear-inducing Ebola virus is reportedly much older than previously thought, dating back 16 to 23 million years, and has interacted with mammals for a long time, new research shows.
Earlier today, the US Centers for Disease Control and Prevention (CDC) confirmed that a new imported case of Ebola has developed in an American health worker. His chances of survival look positive, and experts are saying that his blood, along with the blood of other survivors, could potentially help treat the disease.
Researchers are arguing that some very lucky individuals may be naturally immune to Ebola infection, and finding them could open doors for treatment and disease containment not even considered.
A United States health worker has tested positive for the Ebola virus, making them the first US citizen to contract the infection and the second person to come down with symptoms while in the country. Still, experts are quick to note that the victim was caring for the first US case, and the disease is likely still contained.